Gene Editing Will Change Medicine—and Maybe Health Investing Too
It usually takes time for scientific discoveries in the lab to make their way to the market.The groundbreaking gene-editing technology ...
Friday, September 12, 2025
Tag: Genomics
Icahn Is No Saint, but Illumina Can Still Use a Flawed Savior
Despite a short seller’s accusations that his company has inflated its asset prices, Carl Icahn’s effort to shake up Illumina’s ...
WSJ News Exclusive | Farallon Capital to Wage Proxy Battle at Biotech Firm
WSJ News ExclusiveFinanceFarallon has nominated three directors to the board of Exelixis
WSJ News Exclusive | Bio-Rad Laboratories in Talks to Combine With Qiagen
Bio-Rad Laboratories is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth ...
EDITOR'S PICK
EP NEWSROOM
© 2025 Edinburg Post or its affiliated companies.